T43.655
Adverse effect of methamphetamines
Clinical Classification Guidelines
Medical Intelligence & Overview
The international classification ICD-10 code T43.655 refers to adverse effects caused by methamphetamines. Methamphetamines are powerful stimulant drugs that have a high potential for misuse and can lead to serious health problems. This code is used in medical records to classify cases where individuals experience harmful side effects due to methamphetamine use, whether intentional or accidental. Recognizing these adverse effects is vital for healthcare providers to diagnose, manage, and treat affected individuals appropriately.
Causes & Symptoms
Clinical Causes: Use of methamphetamines for recreational or non-medical purposes Accidental overdose or poisoning Prolonged or high-dose usage leading to toxicity Combination with other stimulants or substances that exacerbate adverse effects Chronic use resulting in long-term health complications
Key Symptoms: Increased heart rate and blood pressure Severe agitation or irritability Anxiety and paranoia Dilated pupils Chest pain or discomfort Nausea and vomiting Hyperthermia (elevated body temperature) Respiratory issues Sweating and chills Seizures Hallucinations or psychosis Potential for accidents or injuries due to impaired judgment Dependence and withdrawal symptoms with repeated use
Diagnostic & Treatment
Diagnosis Path: Healthcare providers diagnose adverse effects of methamphetamines through a detailed medical history, physical examinations, and laboratory tests. Toxicology screenings can confirm recent methamphetamine exposure. Medical professionals may also evaluate the individual's mental status, vital signs, and organ functions to assess the extent of effects. Accurate documentation ensures proper coding, management, and treatment planning for affected patients.
Treatment Protocols: Treatment strategies typically include medical stabilization to address acute symptoms, such as controlling heart rate, blood pressure, and temperature. Supportive care in a medical facility might involve intravenous fluids, sedation, or medications to manage agitation and seizures. Long-term management may involve counseling, behavioral therapy, and support groups aimed at substance use disorder. In some cases, medications might be prescribed to assist with cravings or withdrawal symptoms, but these should be administered under medical supervision. Preventive measures include education, addiction treatment, and harm reduction programs aimed at minimizing risks associated with methamphetamine use.
Clinical Advice & FAQs
Billing Guidance
Is T43.655 a billable ICD-10 code?
Yes, T43.655 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T43.655?
Clinical documentation must specify the nature of Adverse effect of methamphetamines and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
